jump to navigation

ReDent-Nova has raised $2.7 million from Infinity Venture Capital and Maayan Ventures July 7, 2006

Posted by israelhealthcare in Endodontic Dentistry, Endoscopic Solutions.
Tags: ,
add a comment

ReDent-Nova, a developer of a self adjusting file (SAF) for endodontic dentistry, has raised $2.7 million from Israeli venture capital fund Infinity Venture Capital, Maayan Ventures, Infinity’s technology incubator, and private investors.

The investment money will be used to complete the development of the SAF, to support ReDent’s clinical trials of the device and to see the company through the U.S. regulatory process.

27 million root canal treatments are performed in the U.S. annually. 25 million root canal treatments are performed yearly in Western Europe. Currently, root canal treatments require the use of a series of metal files varying in width, strength and diameter. This result in a time consuming procedure that does not always disinfect well, produce a complete cleaning, or satisfactorily remove the tooth’s pulp. These are all necessary elements for a successful root canal.

“The creation of the SAF signifies the beginning of a new era in endodontic dentistry. The SAF enables a complete and successful root canal operation and with the use of only one file. The SAF improves the cleaning and the shaping of the root canal by adjusting itself to the formation of the root canal. The SAF follows the contours of the root canal and enlarges it to a greater dimension while maintaining its original shape. The benefit of these deliverables, among others, is less chair time for the dentist and the patient,” explained Ofer Shalev, CEO of ReDent-NOVA.

Sponsored Links Compression Therapy for Lymphedema | Garlic health benefits

Advertisements

Stryker has acquired Israeli endoscopic solutions developer Sightline for $50 million March 20, 2006

Posted by israelhealthcare in Endoscopic Solutions.
add a comment

US medical technology company, Stryker has acquired Israeli endoscopic solutions developer Sightline Technologies, for $50 million in cash. Stryker has also agreed to make milestone payments of up to an additional $90 million upon the achievement of certain operational and financial targets related to Sightline’s products, the first of which is not expected to occur before 2007.

Sightline, a developer of flexible endoscopes for the gastrointestinal (GI), has developed a technology that should improve insertion and sterilization during colonoscopy procedures. Two Sightline products that are currently available in the market are: RectoSight and ProctoSight – for rectal procedures. In addition, Sightline has developed the ThimbleCam, a finger camera for surgical and laparoscopic procedures.

“Stryker is a leader in the rigid endoscopy market. This acquisition allows us to apply our core competencies in visualization technology and sales and marketing to the flexible endoscopy market. Additionally, Sightline will potentially open up new markets for our Communications and Video Accessories businesses,” stated Bill Enquist, President of Stryker Global Endoscopy.

Stryker engages in the development, manufacture, and marketing of orthopedic products and medical specialties worldwide. The Company’s products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems. The company was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Sponsored Links – Brain Training for Boomers | Senior Medical Alarm
Device